Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Horizon Therapeutics (HZNP)
Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 22,734,172
  • Shares Outstanding, K 228,622
  • Annual Sales, $ 3,629 M
  • Annual Income, $ 521,480 K
  • 60-Month Beta 1.12
  • Price/Sales 6.29
  • Price/Cash Flow 14.13
  • Price/Book 4.47
Trade HZNP with:

Options Overview Details

View History
  • Implied Volatility 22.78% ( +1.09%)
  • Historical Volatility 46.84%
  • IV Percentile 41%
  • IV Rank 19.66%
  • IV High 84.56% on 12/09/22
  • IV Low 7.67% on 01/17/23
  • Put/Call Vol Ratio 7.51
  • Today's Volume 68,689
  • Volume Avg (30-Day) 54,840
  • Put/Call OI Ratio 1.53
  • Today's Open Interest 719,823
  • Open Int (30-Day) 543,082

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate 1.12
  • Number of Estimates 4
  • High Estimate 1.23
  • Low Estimate 1.02
  • Prior Year 1.07
  • Growth Rate Est. (year over year) +4.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
90.56 +10.06%
on 05/16/23
112.38 -11.31%
on 05/15/23
-11.17 (-10.08%)
since 05/08/23
3-Month
90.56 +10.06%
on 05/16/23
112.76 -11.61%
on 05/05/23
-10.13 (-9.23%)
since 03/08/23
52-Week
57.84 +72.32%
on 09/01/22
113.83 -12.44%
on 12/30/22
+9.06 (+10.00%)
since 06/08/22

Most Recent Stories

More News
Is AbbVie or Amgen the Better Bargain Buy Right Now?

These elite drugmakers are both working through a number of headwinds.

TEVA : 7.44 (+0.81%)
ABBV : 137.54 (+0.76%)
AMGN : 220.86 (-0.18%)
HZNP : 99.72 (+0.28%)
Is Amgen a Good Dividend Stock?

The biotech's yield is near an all-time high right now.

AMGN : 220.86 (-0.18%)
HZNP : 99.72 (+0.28%)
3 Stocks Worth Buying at 52-Week Lows

Here are three stocks that are trading near their 52-week lows and may be primed for a short-term rally for opportunistic investors

KDP : 31.31 (-0.05%)
MNST : 57.14 (+0.42%)
PFE : 39.03 (+0.36%)
SGEN : 195.00 (+0.13%)
AMGN : 220.86 (-0.18%)
HZNP : 99.72 (+0.28%)
CVS : 71.50 (+0.03%)
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?

Should Pfizer and Seagen investors be worried?

HZNP : 99.72 (+0.28%)
AMGN : 220.86 (-0.18%)
PFE : 39.03 (+0.36%)
SGEN : 195.00 (+0.13%)
Is Pfizer's Seagen Deal In Jeopardy Amid Antitrust Scrutiny?

Despite worries about FTC scrutiny, Pfizer remains optimistic about its planned Seagen acquisition, issuing $31 billion in bonds to finance the deal.

PFE : 39.03 (+0.36%)
SGEN : 195.00 (+0.13%)
AMGN : 220.86 (-0.18%)
HZNP : 99.72 (+0.28%)
FTC Seeks to Block Amgen's Acquisition of Horizon Therapeutics: What's Next for Both Stocks?

Don't bank on the FTC winning in its attempt to stop Amgen's buyout of Horizon just yet.

AMGN : 220.86 (-0.18%)
HZNP : 99.72 (+0.28%)
Is This Dow Jones Stock a Buy for Income Investors?

This pharmaceutical company is dedicated to maintaining its track record of innovation.

PFE : 39.03 (+0.36%)
AMGN : 220.86 (-0.18%)
HZNP : 99.72 (+0.28%)
Stocks Undercut as Little Progress is seen in U.S. Debt Ceiling Talks

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.63%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -1.01%, and the Nasdaq 100 Index ($IU ) (QQQ ) closed up...

$SPX : 4,282.51 (+0.35%)
SPY : 428.18 (+0.38%)
$DOWI : 33,811.23 (+0.43%)
DIA : 338.59 (+0.42%)
$IUXX : 14,421.64 (+0.83%)
QQQ : 351.71 (+0.83%)
HD : 302.22 (+0.17%)
CZR : 48.68 (+0.14%)
ETSY : 87.64 (+0.08%)
MHK : 98.77 (-2.41%)
WHR : 143.66 (-1.59%)
SGEN : 195.00 (+0.13%)
Why These 3 Nasdaq Stocks Buckled Today

The FTC's decision to sue to block a high-profile merger is weighing on biotech valuations today.

XBI : 88.15 (-0.07%)
APLS : 89.90 (-2.42%)
MDGL : 273.55 (-1.06%)
SRPT : 126.62 (-1.00%)
AMGN : 220.86 (-0.18%)
HZNP : 99.72 (+0.28%)
Why These 2 Large-Cap Stocks Dropped 10%-Plus on Tuesday

Their declines weighed on the broader market.

COMP : 3.73 (-4.11%)
SE : 63.56 (+4.25%)
HZNP : 99.72 (+0.28%)
AMGN : 220.86 (-0.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Horizon Therapeutics plc is a biopharmaceutical focused on making drugs in arthritis, pain, inflammatory and orphan diseases areas.

See More

Key Turning Points

3rd Resistance Point 101.00
2nd Resistance Point 100.62
1st Resistance Point 100.03
Last Price 99.72
1st Support Level 99.06
2nd Support Level 98.68
3rd Support Level 98.09

See More

52-Week High 113.83
Last Price 99.72
Fibonacci 61.8% 92.44
Fibonacci 50% 85.83
Fibonacci 38.2% 79.23
52-Week Low 57.84

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar